We have approved a fourth vaccine, with the goal of addressing vaccine hesitancy. But hesitancy is irrational and unlikely to ...
We teach medicine through memory. But memorizing facts does little to address the uncertainty that comes out of making decisions ...
Medicine has always relied on intuition, that prescient gut instinct. But intuition is outcomes focused. Instead, we need logic, which ...
A better understanding of the pandemic’s effects on young people is essential to developing policy responses that can address the ...
With viruses dominating headlines, it is no surprise that the latest Monkeypox outbreak garners headlines. But the way we cover ...
For most, prescribing antibiotics is a simple decision made reflexively. However, that decision, seemingly logical in the moment, becomes dangerous ...
In game theory, outcomes depend on the nature of the game and the payoffs. Healthcare is a game of incomplete ...
The CDC must decide whether to proceed with a new generation of vaccines that promise longer immunity. But many unknowns ...
A call for an independent investigation into the origins of COVID-19 renews interest in the virus's mutation patterns. It also ...
This summer promises to be tumultuous with many polarizing health issues coming to a head. The pending convergence provides an ...
Medicine and law have strained their relationship, butting heads on a host of issues of late. The problem lies in ...
In recent weeks, a slew of newly enacted health laws or revised interpretations emerged. Despite the changes, the means to ...
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read moreDaily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.
Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.
© 2026 Daily Remedy
© 2026 Daily Remedy